Literature DB >> 19082992

Measurement of the lowest dosage of phenobarbital that can produce drug discrimination in rats.

Donald A Overton1, Gregg D Stanwood, Bhavesh N Patel, Sreenivasa R Pragada, M Kathleen Gordon.   

Abstract

RATIONALE: Accurate measurement of the threshold dosage of phenobarbital that can produce drug discrimination (DD) may improve our understanding of the mechanisms and properties of such discrimination.
OBJECTIVES: This study aimed to compare three methods for determining the threshold dosage for phenobarbital (D) versus no-drug (N) DD.
MATERIALS AND METHODS: Rats learned a D versus N DD in two-lever operant training chambers. A titration scheme was employed to increase or decrease dosage at the end of each 18-day block of sessions depending on whether the rat had achieved criterion accuracy during the sessions just completed. Three criterion rules were employed, all based on average percent drug lever responses during initial links of the last six D and six N sessions of a block. The criteria were: D% > 66 and N% < 33; D% > 50, and N% < 50; (D% - N%) > 33. Two squads of rats were trained, one immediately after the other.
RESULTS: All rats discriminated drug versus no drug. In most rats, dosage decreased to low levels and then oscillated near the minimum level required to maintain criterion performance. The lowest discriminated dosage significantly differed under the three criterion rules. The squad that was trained second may have benefited by partially duplicating the lever choices of the previous squad.
CONCLUSIONS: The lowest discriminated dosage is influenced by the criterion of discriminative control that is employed and is higher than the absolute threshold at which discrimination entirely disappears. Threshold estimations closer to absolute threshold can be obtained when criteria are employed that are more permissive of errors and that allow rats to maintain lever preferences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082992      PMCID: PMC2782425          DOI: 10.1007/s00213-008-1426-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose.

Authors:  K L Preston; G E Bigelow
Journal:  Behav Pharmacol       Date:  1998-11       Impact factor: 2.293

2.  Threshold doses for nicotine discrimination in smokers and non-smokers.

Authors:  K A Perkins; C Fonte; M Sanders; J Meeker; A Wilson
Journal:  Psychopharmacology (Berl)       Date:  2001-05       Impact factor: 4.530

3.  Inter-animal olfactory cues in operant drug discrimination procedures in rats.

Authors:  K Extance; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

4.  Differential haloperidol effect on two indices of fentanyl-saline discrimination.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1977-07-18       Impact factor: 4.530

5.  Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

Authors:  D A Overton
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Factors regulating drug cue sensitivity: limits of discriminability and the role of a progressively decreasing training dose in fentanyl-saline discrimination.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

7.  Factors regulating drug cue sensitivity: the effect of training dose in fentanyl-saline discrimination.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Neuropharmacology       Date:  1980-08       Impact factor: 5.250

8.  Drug discrimination learning in lead-exposed rats.

Authors:  H Zenick; M Goldsmith
Journal:  Science       Date:  1981-05-01       Impact factor: 47.728

9.  Drug discrimination training with progressively lowered doses.

Authors:  D A Overton
Journal:  Science       Date:  1979-08-17       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.